Nurcombe V - Search Results

1

Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.

Vanhecke E, Adriaenssens E, Verbeke S, Meignan S, Germain E, Berteaux N, Nurcombe V, Le Bourhis X, Hondermarck H. Vanhecke E, et al. Among authors: nurcombe v. Clin Cancer Res. 2011 Apr 1;17(7):1741-52. doi: 10.1158/1078-0432.CCR-10-1890. Epub 2011 Feb 24. Clin Cancer Res. 2011. PMID: 21350004

2

Nerve growth factor overexpression and autocrine loop in breast cancer cells.

Dollé L, El Yazidi-Belkoura I, Adriaenssens E, Nurcombe V, Hondermarck H. Dollé L, et al. Among authors: nurcombe v. Oncogene. 2003 Aug 28;22(36):5592-601. doi: 10.1038/sj.onc.1206805. Oncogene. 2003. PMID: 12944907

3

Nerve growth factor receptors and signaling in breast cancer.

Dollé L, Adriaenssens E, El Yazidi-Belkoura I, Le Bourhis X, Nurcombe V, Hondermarck H. Dollé L, et al. Among authors: nurcombe v. Curr Cancer Drug Targets. 2004 Sep;4(6):463-70. doi: 10.2174/1568009043332853. Curr Cancer Drug Targets. 2004. PMID: 15379632 Review.

4

Nerve growth factor is a potential therapeutic target in breast cancer.

Adriaenssens E, Vanhecke E, Saule P, Mougel A, Page A, Romon R, Nurcombe V, Le Bourhis X, Hondermarck H. Adriaenssens E, et al. Among authors: nurcombe v. Cancer Res. 2008 Jan 15;68(2):346-51. doi: 10.1158/0008-5472.CAN-07-1183. Cancer Res. 2008. PMID: 18199526

5

Proteomics of breast cancer: outcomes and prospects.

El Yazidi-Belkoura I, Adriaenssens E, Vercoutter-Edouart AS, Lemoine J, Nurcombe V, Hondermarck H. El Yazidi-Belkoura I, et al. Among authors: nurcombe v. Technol Cancer Res Treat. 2002 Aug;1(4):287-96. doi: 10.1177/153303460200100410. Technol Cancer Res Treat. 2002. PMID: 12625788 Free article. Review.

6

Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells.

Vercoutter-Edouart AS, Lemoine J, Le Bourhis X, Louis H, Boilly B, Nurcombe V, Révillion F, Peyrat JP, Hondermarck H. Vercoutter-Edouart AS, et al. Among authors: nurcombe v. Cancer Res. 2001 Jan 1;61(1):76-80. Cancer Res. 2001. PMID: 11196201

7

Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways.

Descamps S, Toillon RA, Adriaenssens E, Pawlowski V, Cool SM, Nurcombe V, Le Bourhis X, Boilly B, Peyrat JP, Hondermarck H. Descamps S, et al. Among authors: nurcombe v. J Biol Chem. 2001 May 25;276(21):17864-70. doi: 10.1074/jbc.M010499200. Epub 2001 Feb 28. J Biol Chem. 2001. PMID: 11359788 Free article.

8

The mitogenic signaling pathway for fibroblast growth factor-2 involves the tyrosine phosphorylation of cyclin D2 in MCF-7 human breast cancer cells.

Vercoutter-Edouart A, Lemoine J, Smart CE, Nurcombe V, Boilly B, Peyrat J, Hondermarck H. Vercoutter-Edouart A, et al. Among authors: nurcombe v. FEBS Lett. 2000 Aug 4;478(3):209-15. doi: 10.1016/s0014-5793(00)01855-x. FEBS Lett. 2000. PMID: 10930570 Free article.

9

FGF signals for cell proliferation and migration through different pathways.

Boilly B, Vercoutter-Edouart AS, Hondermarck H, Nurcombe V, Le Bourhis X. Boilly B, et al. Among authors: nurcombe v. Cytokine Growth Factor Rev. 2000 Dec;11(4):295-302. doi: 10.1016/s1359-6101(00)00014-9. Cytokine Growth Factor Rev. 2000. PMID: 10959077 Review.

10

Proteomics of breast cancer for marker discovery and signal pathway profiling.

Hondermarck H, Vercoutter-Edouart AS, Révillion F, Lemoine J, el-Yazidi-Belkoura I, Nurcombe V, Peyrat JP. Hondermarck H, et al. Among authors: nurcombe v. Proteomics. 2001 Oct;1(10):1216-32. doi: 10.1002/1615-9861(200110)1:10<1216::AID-PROT1216>3.0.CO;2-P. Proteomics. 2001. PMID: 11721634 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page